The Japanese government will strengthen efforts to ensure foreign residents are enrolled in the country's public pension program by accessing relevant information during the migration process, sources close to the matter say.
/PRNewswire/ Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA).
Astellas Pharma Inc. announced that the U.S. Food and Drug Administration has acknowledged the company s resubmission of the Biologics License Application for zolbetuximab, a first-in-class.
Taiwan's Food and Drug Administration (TFDA) said Wednesday that the Japanese government's confirmation that a toxic substance found in red yeast rice supplements produced by Kobayashi Pharmaceutical Co. may cause kidney damage is favorable to consumers in Taiwan who might seek compensation.